SHCBP1 and non-small cell lung carcinoma: Meanwhile, we found that patients bearing lung tumors with a high level of nuclear SHCBP1 had a shorter overall survival time, indicating that nuclear SHCBP1 could be a causative factor for tumor progression and represent a valuable biomarker for the prognosis of NSCLC (Fig. 8b).